EquityZen Growth Technology Fund LLC - Series 2029
Raised
$161K
Investors
14
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2029 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC on 2025-03-26, raising $161K from 14 investors under Rule 506(b) and Section 3(c)(1) exemptions. The offering has a $10K minimum investment and is part of EquityZen's pre-IPO secondary market platform with 1,889 related EDGAR entities.
This pre-IPO fund follows a standard EquityZen series structure with modest raise size and retail-accessible minimums ($10K), consistent with pooled secondary share vehicles targeting accredited investors. The dual 506(b)/3(c)(1) exemption pattern is typical for sub-100 investor private funds avoiding registration as investment companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
